Clinical Trial Update: A Phase 3 Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TB [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of B-Pa-L for drug-resistant pulmonary tuberculosis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• B-Pa-L

Snippet

Sponsor: Global Alliance for TB Drug Development | Conditions: Pulmonary Tuberculosis | Phase 3 | Status: COMPLETED | Results posted: 2024-08-09